| Primary |
| Hepatitis C |
76.2% |
| Chronic Hepatitis C |
8.9% |
| Product Used For Unknown Indication |
4.0% |
| Drug Use For Unknown Indication |
1.5% |
| Hypertension |
1.4% |
| Hepatitis C Virus |
1.1% |
| Hiv Infection |
1.0% |
| Hepatitis C Virus Test |
0.8% |
| Hepatitis |
0.6% |
| Anaemia |
0.6% |
| Hepatic Cirrhosis |
0.6% |
| Prophylaxis |
0.5% |
| Immunosuppression |
0.4% |
| Chronic Hepatitis |
0.4% |
| Insomnia |
0.3% |
| Depression |
0.3% |
| Liver Disorder |
0.3% |
| Thrombocytopenia |
0.3% |
| Liver Transplant |
0.3% |
| Diabetes Mellitus |
0.3% |
|
| White Blood Cell Count Decreased |
13.7% |
| Rash |
11.2% |
| Vomiting |
10.9% |
| Weight Decreased |
10.5% |
| Anaemia |
10.4% |
| Thrombocytopenia |
5.4% |
| Pyrexia |
3.8% |
| Syncope |
3.7% |
| Drug Ineffective |
3.3% |
| Pruritus |
3.1% |
| Suicidal Ideation |
2.9% |
| Nausea |
2.6% |
| Pancytopenia |
2.6% |
| Malaise |
2.5% |
| Retinopathy |
2.5% |
| Fatigue |
2.4% |
| Renal Failure Acute |
2.3% |
| Haemoglobin Decreased |
2.2% |
| Rash Pruritic |
2.1% |
| Type 1 Diabetes Mellitus |
2.0% |
|
| Secondary |
| Hepatitis C |
69.0% |
| Chronic Hepatitis C |
15.6% |
| Product Used For Unknown Indication |
3.9% |
| Hypertension |
1.9% |
| Drug Use For Unknown Indication |
1.6% |
| Hiv Infection |
1.3% |
| Depression |
1.2% |
| Insomnia |
0.8% |
| Hepatic Cirrhosis |
0.6% |
| Diabetes Mellitus |
0.5% |
| Thrombocytopenia |
0.5% |
| Anxiety |
0.5% |
| Pain |
0.4% |
| Prophylaxis |
0.4% |
| Anaemia |
0.4% |
| Nausea |
0.3% |
| Dermatitis |
0.3% |
| Asthma |
0.3% |
| Rash |
0.3% |
| Hypothyroidism |
0.3% |
|
| White Blood Cell Count Decreased |
22.5% |
| Rash |
12.0% |
| Weight Decreased |
11.8% |
| Vomiting |
11.2% |
| Nausea |
4.0% |
| Pyrexia |
3.7% |
| Pruritus |
3.5% |
| Thrombocytopenia |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Anaemia |
3.1% |
| Fatigue |
3.1% |
| Weight Increased |
2.6% |
| Syncope |
2.4% |
| Rash Pruritic |
2.3% |
| Platelet Count Decreased |
2.1% |
| Drug Ineffective |
2.1% |
| Retinopathy |
1.9% |
| Haemoglobin Decreased |
1.8% |
| Pneumonia |
1.7% |
| Rash Generalised |
1.6% |
|
| Concomitant |
| Hepatitis C |
86.1% |
| Hiv Infection |
2.3% |
| Product Used For Unknown Indication |
2.2% |
| Hypertension |
1.8% |
| Chronic Hepatitis C |
1.4% |
| Depression |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Pain |
0.8% |
| Diabetes Mellitus |
0.7% |
| Anaemia |
0.6% |
| Anxiety |
0.4% |
| Hypothyroidism |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Prophylaxis |
0.3% |
| Blood Pressure |
0.2% |
| Insomnia |
0.2% |
| Medical Diet |
0.2% |
| Liver Transplant |
0.2% |
| Pre-existing Disease |
0.2% |
| Schizophrenia |
0.2% |
|
| Rash |
17.1% |
| White Blood Cell Count Decreased |
10.3% |
| Anaemia |
8.7% |
| Vomiting |
7.1% |
| Nausea |
7.1% |
| Fatigue |
5.9% |
| Pruritus |
5.6% |
| Weight Decreased |
3.7% |
| Pyrexia |
3.6% |
| Rash Pruritic |
3.6% |
| Haemoglobin Decreased |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Rash Generalised |
3.2% |
| Decreased Appetite |
3.2% |
| Drug Ineffective |
2.8% |
| Platelet Count Decreased |
2.6% |
| Renal Impairment |
2.4% |
| Diarrhoea |
2.3% |
| Headache |
2.2% |
| Influenza Like Illness |
2.1% |
|
| Interacting |
| Hepatitis C |
39.5% |
| Chronic Hepatitis C |
7.9% |
| Depression |
6.1% |
| Drug Use For Unknown Indication |
5.7% |
| Product Used For Unknown Indication |
5.3% |
| Asthma |
4.8% |
| Constipation |
4.8% |
| Dyspepsia |
4.8% |
| Hiv Infection |
4.8% |
| Hypertension |
4.8% |
| Immune Reconstitution Syndrome |
2.6% |
| Hepatitis C Virus |
2.2% |
| Hepatitis C Antibody Positive |
1.3% |
| Pulmonary Embolism |
1.3% |
| Chronic Hepatitis |
0.9% |
| Influenza |
0.9% |
| Thyroidectomy |
0.9% |
| Essential Hypertension |
0.4% |
| Hypothyroidism |
0.4% |
| Liver Transplant |
0.4% |
|
| Drug Interaction |
14.3% |
| Neutropenia |
14.3% |
| Pneumonia |
8.2% |
| White Blood Cell Count Decreased |
8.2% |
| Polyneuropathy |
6.1% |
| Pulmonary Embolism |
6.1% |
| Rash Generalised |
6.1% |
| Thrombocytopenia |
6.1% |
| Hepatitis C |
4.1% |
| Vomiting |
4.1% |
| Weight Decreased |
4.1% |
| Activities Of Daily Living Impaired |
2.0% |
| Asthenia |
2.0% |
| Cerebral Haemorrhage |
2.0% |
| Depressed Level Of Consciousness |
2.0% |
| Fat Tissue Increased |
2.0% |
| Neutrophil Count Decreased |
2.0% |
| Pancreatitis Acute |
2.0% |
| Peripheral Coldness |
2.0% |
| Platelet Count Decreased |
2.0% |
|
